哺乳动物雷帕霉素靶蛋白复合物1介导的自噬对骨代谢的调控

doi:10.7518/gjkq.2020005

国际口腔医学杂志 ›› 2020, Vol. 47 ›› Issue (1): 84-89.doi: 10.7518/gjkq.2020005

哺乳动物雷帕霉素靶蛋白复合物1介导的自噬对骨代谢的调控

朱俊瑾¹,周佳琦¹,伍颖颖^2,()

^1. 口腔疾病研究国家重点实验室国家口腔疾病临床医学研究中心四川大学华西口腔医学院成都 610041
^2. 口腔疾病研究国家重点实验室国家口腔疾病临床医学研究中心四川大学华西口腔医院种植科成都 610041

收稿日期:2019-05-12 修回日期:2019-10-09 出版日期:2020-01-01 发布日期:2020-01-01
通讯作者: 伍颖颖
作者简介:朱俊瑾,学士,Email： 512391940@qq.com
基金资助:
四川省科学技术厅科技创新苗子工程(2018RZ0088)

Function of autophagy induced by mammalian target of rapamycin complex 1 in bone metabolism

Zhu Junjin¹,Zhou Jiaqi¹,Wu Yingying^2,()

^1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & West China School of Stomatology, Sichuan University, Chengdu 610041, China
^2. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Implantology, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China

Received:2019-05-12 Revised:2019-10-09 Online:2020-01-01 Published:2020-01-01
Contact: Yingying Wu
Supported by:
This study was supported by Sichuan Science and Technology Innovation Seedling Project(2018RZ0088)

摘要/Abstract

摘要：

哺乳动物雷帕霉素靶蛋白复合物（mTORC）1是哺乳动物雷帕霉素靶蛋白形成的一种复合物,在细胞合成代谢过程中起重要作用,其参与调控的自噬作用近年来受到广泛关注。自噬是细胞降解损坏的蛋白质或细胞器并将其循环利用的过程。随着对mTORC1/自噬效应的研究逐渐深入,其在骨代谢方面的调控作用愈发凸显。本文就mTORC1介导的自噬通路在成骨细胞、破骨细胞等骨相关细胞方面的作用及其机制进行综述,为骨代谢的生物学机制和骨组织疾病的研究提供新思路。

关键词: 哺乳动物雷帕霉素靶蛋白复合物, 自噬, 成骨细胞, 破骨细胞

Abstract:

The mammalian target of rapamycin (mTOR) forms two functionally distinct multiprotein complexes, one of which is the mammalian target of rapamycin complex 1 (mTORC1). The mTORC1 plays a central role in regulating anabolic processes, including autophagy, which has recently captured extensive attention. Autophagy is an intracellular recycling pathway in which cellular components, including protein aggregates and organelles, are targeted to the lysosome for degradation. In recent years, an increasing amount of evidence shows that autophagy is mediated by mTORC1, which plays a critical role in bone metabolism. This review summarises the important role and mechanism of mTORC1-mediated autophagy in bone-related cells, especially osteoblasts and osteoclasts.

Key words: mammalian target of rapamycin complex, autophagy, osteoblast, osteoclast

中图分类号:

Q251

朱俊瑾,周佳琦,伍颖颖. 哺乳动物雷帕霉素靶蛋白复合物1介导的自噬对骨代谢的调控[J]. 国际口腔医学杂志, 2020, 47(1): 84-89.

Zhu Junjin,Zhou Jiaqi,Wu Yingying. Function of autophagy induced by mammalian target of rapamycin complex 1 in bone metabolism[J]. Int J Stomatol, 2020, 47(1): 84-89.

参考文献 36

[1]	Potter CJ, Pedraza LG, Xu T . Akt regulates growth by directly phosphorylating Tsc2[J]. Nat Cell Biol, 2002,4(9):658-665.
[2]	Ma L, Chen Z, Erdjument-Bromage H , et al. Pho-sphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis[J]. Cell, 2005,121(2):179-193.
[3]	Laplante M , Sabatini DM. mTOR signaling in growth control and disease[J]. Cell, 2012,149(2):274-293.
[4]	Martina JA, Chen Y, Gucek M , et al. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB[J]. Auto-phagy, 2012,8(6):903-914.
[5]	Hua Y, Shen M ,McDonald C,et al.Autophagy dys-function in autoinflammatory diseases[J]. J Autoimmun, 2018,88:11-20.
[6]	Rockel JS, Kapoor M . Autophagy: controlling cell fate in rheumatic diseases[J]. Nat Rev Rheumatol, 2016,12(9):517-531.
[7]	Yang Z, Klionsky DJ . Mammalian autophagy: core molecular machinery and signaling regulation[J]. Curr Opin Cell Biol, 2010,22(2):124-131.
[8]	Jung CH, Jun CB, Ro SH , et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the auto-phagy machinery[J]. Mol Biol Cell, 2009,20(7):1992-2003.
[9]	Duran A, Amanchy R, Linares JF , et al. p62 is a key regulator of nutrient sensing in the mTORC1 path-way[J]. Mol Cell, 2011,44(1):134-146.
[10]	Liu YQ, Hong ZL, Zhan LB , et al. Wedelolactone enhances osteoblastogenesis by regulating Wnt/β- atenin signaling pathway but suppresses osteoclasto-genesis by NF-κB/c-fos/NFATc1 pathway[J]. Sci Rep, 2016,6:32260.
[11]	Chen Q, Shou P, Zheng C , et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts[J]. Cell Death Differ, 2016,23(7):1128-1139.
[12]	Greco EA, Lenzi A, Migliaccio S . The obesity of bone[J]. Ther Adv Endocrinol Metab, 2015,6(6):273-286.
[13]	Chen C, Akiyama K, Wang D , et al. mTOR inhibitiontion rescues osteopenia in mice with systemic sclerosis[J]. J Exp Med, 2015,212(1):73-91.
[14]	Qi M, Zhang L, Ma Y , et al. Autophagy maintains the function of bone marrow mesenchymal stem cells to prevent estrogen deficiency-induced osteo-porosis[J]. Theranostics, 2017,7(18):4498-4516.
[15]	Yin ZY, Yin J, Huo YF , et al. Rapamycin facilitates fracture healing through inducing cell autophagy and suppressing cell apoptosis in bone tissues[J]. Eur Rev Med Pharmacol Sci, 2017,21(21):4989-4998.
[16]	Zhou Z, Shi G, Zheng X , et al. Autophagy activation facilitates mechanical stimulation-promoted osteo-blast differentiation and ameliorates hindlimb un-loading-induced bone loss[J]. Biochem Biophys Res Commun, 2018,498(3):667-673.
[17]	Piemontese M, Onal M, Xiong J , et al. Low bone mass and changes in the osteocyte network in mice lacking autophagy in the osteoblast lineage[J]. Sci Rep, 2016,6:24262.
[18]	Liu F, Fang F, Yuan H , et al. Suppression of auto-phagy by FIP200 deletion leads to osteopenia in mice through the inhibition of osteoblast terminal differentiation[J]. J Bone Miner Res, 2013,28(11):2414-2430.
[19]	Pantovic A, Krstic A, Janjetovic K , et al. Coordinated time-dependent modulation of AMPK/Akt/mTOR signaling and autophagy controls osteogenic dif-ferentiation of human mesenchymal stem cells[J]. Bone, 2013,52(1):524-531.
[20]	Liu Y, Kou X, Chen C , et al. Chronic high dose alcohol induces osteopenia via activation of mTOR signaling in bone marrow mesenchymal stem cells[J]. Stem Cells, 2016,34(8):2157-2168.
[21]	Nollet M, Santucci-Darmanin S, Breuil V , et al. Autophagy in osteoblasts is involved in mineraliza-tion and bone homeostasis[J]. Autophagy, 2014,10(11):1965-1977.
[22]	余守和, 洪岸 . Runx2通过抑制细胞巨自噬以诱导C2C12细胞向成骨细胞分化[J]. 中国病理生理杂志, 2013,29(3):481-487.
	Yu SH, Hong A . Runx2 promotes osteogenic diffe-rentiating C2C12 cells through inhibiting macroauto-phagy[J]. Chin J Pathophysiol, 2013,29(3):481-487.
[23]	Fitter S, Matthews MP, Martin SK , et al. mTORC1 plays an important role in skeletal development by controlling preosteoblast differentiation[J]. Mol Cell Biol, 2017,37(7). doi: 10.1128/MCB.00668-16.
[24]	Thoreen CC, Chantranupong L, Keys HR , et al. A unifying model for mTORC1-mediated regulation of mRNA translation[J]. Nature, 2012,485(7396):109-113.
[25]	Sambandam Y, Townsend MT, Pierce JJ , et al. Mi-cro-gravity control of autophagy modulates osteo-clastogenesis[J]. Bone, 2014,61:125-131.
[26]	Cai ZY, Yang B, Shi YX , et al. High glucose downre-gulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway[J]. Biochem Biophys Res Commun, 2018,503(2):428-435.
[27]	Xiu Y, Xu H, Zhao C , et al. Chloroquine reduces osteoclastogenesis in murine osteoporosis by pre-venting TRAF3 degradation[J]. J Clin Invest, 2014,124(1):297-310.
[28]	Xu S, Zhang Y, Liu B , et al. Activation of mTORC1 in B lymphocytes promotes osteoclast formation via regulation of β-catenin and RANKL/OPG[J]. J Bone Miner Res, 2016,31(7):1320-1333.
[29]	Tong X, Gu J, Song R , et al. Osteoprotegerin inhibit osteoclast differentiation and bone resorption by enhancing autophagy via AMPK/mTOR/p70S6K signaling pathway in vitro[J]. J Cell Biochem, 2018.doi: 10.1002/jcb.27468.
[30]	Dai Q, Xie F, Han Y , et al. Inactivation of regulatory-associated protein of mTOR (raptor)/mammalian target of rapamycin complex 1 (mTORC1) signaling in osteoclasts increases bone mass by inhibiting osteoclast differentiation in mice[J]. J Biol Chem, 2017,292(1):196-204.
[31]	Galson DL, Roodman GD . Pathobiology of Paget’s disease of bone[J]. J Bone Metab, 2014,21(2):85-98.
[32]	McManus S, Bisson M, Chamberland R , et al. Auto-phagy and 3-phosphoinositide-dependent kinase 1 (PDK1)-related kinome in pagetic osteoclasts[J]. J Bone Miner Res, 2016,31(7):1334-1343.
[33]	Plotkin LI, Speacht TL, Donahue HJ . Cx43 and me-chanotransduction in bone[J]. Curr Osteoporos Rep, 2015,13(2):67-72.
[34]	Gao J, Cheng TS, Qin A , et al. Glucocorticoid impairs cell-cell communication by autophagy-me-diated degradation of connexin 43 in osteocytes[J]. Oncotarget, 2016,7(19):26966-26978.
[35]	Onal M, Piemontese M, Xiong J , et al. Suppression of autophagy in osteocytes mimics skeletal aging[J]. J Biol Chem, 2013,288(24):17432-17440.
[36]	Luo D, Ren H, Li T , et al. Rapamycin reduces severity of senile osteoporosis by activating osteocyte auto-phagy[J]. Osteoporos Int, 2016,27(3):1093-1101.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

哺乳动物雷帕霉素靶蛋白复合物1介导的自噬对骨代谢的调控

Function of autophagy induced by mammalian target of rapamycin complex 1 in bone metabolism

RichHTML

PDF (PC)

摘要/Abstract

引用本文

使用本文

参考文献 36

相关文章 15

Metrics

本文评价

推荐阅读 10

[1]	古丽其合热·阿布来提,秦旭,朱光勋. 线粒体自噬在牙周炎发生发展过程中的研究进展[J]. 国际口腔医学杂志, 2024, 51(1): 68-73.
[2]	余岳霖,孔卫东. 甲状旁腺激素受体1基因相关与原发性牙齿萌出障碍的研究进展[J]. 国际口腔医学杂志, 2023, 50(5): 573-580.
[3]	叶玉琳,江莉婷,高益鸣. 舍格伦综合征唾液腺中自噬现象的研究进展[J]. 国际口腔医学杂志, 2022, 49(5): 556-560.
[4]	张静怡,李丹薇,孙宇,雷雅燕,刘涛,龚瑜. 复合树脂及复合体对成骨细胞毒性及成骨向分化的影响[J]. 国际口腔医学杂志, 2022, 49(4): 412-419.
[5]	李归平,秦旭,朱光勋. 腺苷酸活化蛋白激酶在牙周病发生发展中的研究进展[J]. 国际口腔医学杂志, 2022, 49(3): 343-348.
[6]	安宁,李姣,梅志丹. 骨保护素/核因子-κB受体活化因子/核因子κB-受体活化因子配体信号分子调控牙萌出的研究进展[J]. 国际口腔医学杂志, 2022, 49(1): 116-120.
[7]	方苓力,谭玺,叶雨丝,黄兰,何瑶. 颞下颌关节退行性变早期髁突软骨细胞行为改变的实验研究[J]. 国际口腔医学杂志, 2021, 48(4): 417-425.
[8]	周丰,陈野,陈晨,张奕宁,耿瑞蔓,刘戟. 沉默信息调节因子1调控牙周炎发生发展的机制[J]. 国际口腔医学杂志, 2021, 48(3): 341-346.
[9]	尹圆圆,马华钰,李昕怡,徐静晨,柳汀,陈嵩,何姝姝. 小鼠正畸牙移动中牙周组织自噬相关基因表达的初步研究[J]. 国际口腔医学杂志, 2020, 47(6): 627-634.
[10]	吕辉,王华,孙雯. 辅助性T细胞17与牙周炎骨免疫[J]. 国际口腔医学杂志, 2020, 47(6): 661-668.
[11]	付世锦,曾刊,李鑫,杨静,汪成林,叶玲. 骨保护素/核因子κB受体活化因子配体影响肺癌细胞下颌骨与股骨转移差异的初步研究[J]. 国际口腔医学杂志, 2020, 47(5): 538-546.
[12]	孙坚炜,雷利红,谭静怡,陈莉丽. 微小RNA 155对骨免疫的调控及其在牙周炎中作用的研究进展[J]. 国际口腔医学杂志, 2020, 47(5): 607-615.
[13]	杨佩佩,杨羽晨,张强. 尼古丁对牙槽骨破骨细胞的作用及其机制的研究进展[J]. 国际口腔医学杂志, 2020, 47(5): 616-620.
[14]	马凯,李昊,赵红梅,王永亮,刘杰,柏娜. 低温氩氧等离子体处理的无机牛骨对MC3T3-E1细胞黏附、增殖及分化的影响[J]. 国际口腔医学杂志, 2020, 47(3): 278-285.
[15]	卢可心,张迪亚,吴燕岷. 蛋白酶激活受体在牙周组织细胞中相关作用的研究进展[J]. 国际口腔医学杂志, 2019, 46(6): 657-662.